Published online Sep 16, 2020. doi: 10.4253/wjge.v12.i9.256
Peer-review started: May 21, 2020
First decision: June 13, 2020
Revised: July 29, 2020
Accepted: August 31, 2020
Article in press: August 31, 2020
Published online: September 16, 2020
Processing time: 111 Days and 22.9 Hours
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in coronavirus disease 2019 (COVID-19) which has affected more than 4.5 million people in 213 countries, and has been declared a pandemic by World Health Organization on March 11, 2020. The transmission of SARS-CoV-2 has been reported to occur primarily through direct contact or droplets. There have also been reports that SARS-CoV-2 can be detected in biopsy and stool specimens, and it has been postulated that there is potential for fecal–oral transmission as well. Gastrointestinal symptoms have been reported in 17.6% of COVID-19 patients and transmission can potentially occur through gastrointestinal secretions in this group of patients. Furthermore, transmission can also occur in asymptomatic carriers or patients with viral shedding during the incubation period. Endoscopic procedures hence may pose significant risks of transmission (even for those not directly involving confirmed COVID-19 cases) as endoscopists and endoscopy staff are in close contact with patients during these aerosol generating procedures. This could result in inadvertent transmission of infection at time of endoscopy.
Core Tip: Coronavirus pandemic has united the world in taking enhanced measures in the endoscopy center to limit the spread of disease. However, considerable variation exists in the society recommendations that have come out of United States, Canada, Europe, United Kingdom, Australia, Asia and Japan. We summarize these recommendations, provide an overview, and describe our practical application of endoscopy in this challenging times.